Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Genome Landscapes
Bert Vogelstein, Nickolas Papadopoulos, Victor E. Velculescu, et al.
Science (2013) Vol. 339, Iss. 6127, pp. 1546-1558
Open Access | Times Cited: 7295

Showing 1-25 of 7295 citing articles:

The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein, Jun Li, Gordon B. Mills, et al.
Nature Genetics (2013) Vol. 45, Iss. 10, pp. 1113-1120
Open Access | Times Cited: 7594
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder, et al.
Science (2015) Vol. 348, Iss. 6230, pp. 124-128
Open Access | Times Cited: 7182
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda, Mark Sausen, Rebecca Leary, et al.
Science Translational Medicine (2014) Vol. 6, Iss. 224
Open Access | Times Cited: 4454
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth, Michael D. McLellan, Fabio Vandin, et al.
Nature (2013) Vol. 502, Iss. 7471, pp. 333-339
Open Access | Times Cited: 4097
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda, De‐Chen Lin, Yassen Assenov, et al.
Genome Research (2018) Vol. 28, Iss. 11, pp. 1747-1756
Open Access | Times Cited: 3526
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz, Brian J. Abraham, Tong Ihn Lee, et al.
Cell (2013) Vol. 155, Iss. 4, pp. 934-947
Open Access | Times Cited: 3299
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo‐Jack, Alice T. Shaw
Nature Reviews Clinical Oncology (2017) Vol. 15, Iss. 2, pp. 81-94
Closed Access | Times Cited: 2920
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence, Petar Stojanov, Craig H. Mermel, et al.
Nature (2014) Vol. 505, Iss. 7484, pp. 495-501
Open Access | Times Cited: 2919
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sánchez-Vega, Marco Mina, Joshua Armenia, et al.
Cell (2018) Vol. 173, Iss. 2, pp. 321-337.e10
Open Access | Times Cited: 2669
Emerging Biological Principles of Metastasis
Arthur W. Lambert, Diwakar R. Pattabiraman, Robert A. Weinberg
Cell (2017) Vol. 168, Iss. 4, pp. 670-691
Open Access | Times Cited: 2658
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Luke A. Gilbert, Max A. Horlbeck, Britt Adamson, et al.
Cell (2014) Vol. 159, Iss. 3, pp. 647-661
Open Access | Times Cited: 2554
The gut microbiota, bacterial metabolites and colorectal cancer
Petra Louis, Georgina L. Hold, Harry J. Flint
Nature Reviews Microbiology (2014) Vol. 12, Iss. 10, pp. 661-672
Closed Access | Times Cited: 2398
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen, Lu Li, Yuxuan Wang, et al.
Science (2018) Vol. 359, Iss. 6378, pp. 926-930
Open Access | Times Cited: 2299
Wnt signaling in cancer
Tianzuo Zhan, Niklas Rindtorff, Michael Boutros
Oncogene (2016) Vol. 36, Iss. 11, pp. 1461-1473
Open Access | Times Cited: 2248
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue, Robert A. Weinberg
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 10, pp. 611-629
Open Access | Times Cited: 2193
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell, Nicholas McGranahan, Jiří Bártek, et al.
Nature (2013) Vol. 501, Iss. 7467, pp. 338-345
Closed Access | Times Cited: 2168
A comprehensive map of molecular drug targets
Rita Santos, Oleg Ursu, Anna Gaulton, et al.
Nature Reviews Drug Discovery (2016) Vol. 16, Iss. 1, pp. 19-34
Open Access | Times Cited: 2060
Comprehensive Characterization of Cancer Driver Genes and Mutations
Matthew H. Bailey, Collin Tokheim, Eduard Porta‐Pardo, et al.
Cell (2018) Vol. 173, Iss. 2, pp. 371-385.e18
Open Access | Times Cited: 2032
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Díaz, Alberto Bardelli
Journal of Clinical Oncology (2014) Vol. 32, Iss. 6, pp. 579-586
Open Access | Times Cited: 2026
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering, Hayley E. Francies, Joshua M. Francis, et al.
Cell (2015) Vol. 161, Iss. 4, pp. 933-945
Open Access | Times Cited: 2018
Pancreatic cancer
Terumi Kamisawa, Laura D. Wood, Takao Itoi, et al.
The Lancet (2016) Vol. 388, Iss. 10039, pp. 73-85
Closed Access | Times Cited: 1995
A Landscape of Pharmacogenomic Interactions in Cancer
Francesco Iorio, Theo Knijnenburg, Daniël J. Vis, et al.
Cell (2016) Vol. 166, Iss. 3, pp. 740-754
Open Access | Times Cited: 1819
Variation in cancer risk among tissues can be explained by the number of stem cell divisions
Cristian Tomasetti, Bert Vogelstein
Science (2015) Vol. 347, Iss. 6217, pp. 78-81
Open Access | Times Cited: 1798
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox, Stephen W. Fesik, Alec C. Kimmelman, et al.
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 11, pp. 828-851
Open Access | Times Cited: 1763
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie, Charles Lu, Jiayin Wang, et al.
Nature Medicine (2014) Vol. 20, Iss. 12, pp. 1472-1478
Open Access | Times Cited: 1724
Page 1 - Next Page

Scroll to top